Convulsion, Non-Epileptic Clinical Trial
Official title:
Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures
Verified date | January 2018 |
Source | Denver Health and Hospital Authority |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This feasibility study will determine the tolerability of auricular acupuncture, compliance with self-reported seizure tracking, and the quality of a proposed sham acupuncture protocol to inform the design of a large, multi-center, placebo-controlled, double-blind study to demonstrate the therapeutic effect of auricular acupuncture for the treatment of Non-Epileptic Seizures.
Status | Completed |
Enrollment | 29 |
Est. completion date | January 2016 |
Est. primary completion date | January 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: 1. Diagnosis of non-epileptic seizures, confirmed by ictal routine EEG or ictal video EEG 2. Age 18-75 3. Ability to provide informed consent and comply with study activities 4. > 2 NES per month Exclusion Criteria: 1. Serious mental health disorder or medical or neurological illness (requiring systemic treatment and/or hospitalization) until subject either completes therapy or is clinically stable on therapy, in the opinion of the site investigator, for at least 30 days prior to study entry. 2. Pregnancy, self-discovered pregnancy, lactation, or plans to become pregnant. 3. Inability to distinguish between NES and comorbid epileptic seizures. 4. Active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements. 5. Inability or unwillingness of subject or legal guardian/representative to give written informed con-sent. |
Country | Name | City | State |
---|---|---|---|
United States | Denver Health Medical Center | Denver | Colorado |
Lead Sponsor | Collaborator |
---|---|
Denver Health and Hospital Authority |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Completion Rate of Auricular Acupuncture in Patients With NES | Of subjects who receive the first Auricular Acupuncture treatment, we will measure the percentage that goes on to complete the entire 8 week active treatment period. | 8 Weeks | |
Secondary | Adverse Events | We will report the types and rates of any adverse events collected from subject diaries. | 16 Weeks | |
Secondary | Compliance Rates of NES Seizure Diary | For each subject enrolled, we will measure the percentage of diary entries each patient completed over the four month study period. | 16 Weeks | |
Secondary | Trend for Auricular Acupuncture to Reduce NES Frequency | Of subjects completing the 8 week active treatment period, we will compare each subject's 1 month baseline frequency with frequency immediately upon completion of the active treatment period, and at 1 month follow up (3 months after baseline) | 16 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00835627 -
Treatment Trial for Psychogenic Nonepileptic Seizures
|
Phase 4 | |
Active, not recruiting |
NCT05096273 -
Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES
|
N/A | |
Not yet recruiting |
NCT06362161 -
Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND
|
||
Recruiting |
NCT06007053 -
Retraining and Control Therapy (ReACT) R33 Phase
|
N/A | |
Recruiting |
NCT05819268 -
A Multi-site Feasibility Clinical Trial of Retraining and Control Therapy (ReACT), a Mind and Body Treatment for Pediatric Functional Seizures
|
N/A | |
Completed |
NCT02801136 -
Treatment Outcomes of ReACT for PNES
|
N/A | |
Active, not recruiting |
NCT03013348 -
Automated Identification of Psychogenic Nonepileptic Seizures
|
||
Completed |
NCT03369093 -
RCT of Efficacy of Amoxicillin Over Ampicillin on Severe Pneumonia
|
N/A | |
Completed |
NCT00159965 -
Treatments for Psychogenic Nonepileptic Seizures (NES)
|
Phase 4 |